Table 3 Subgroup performance of the H1P2 case definition
From: Development of an administrative definition for celiac disease
Sensitivity (95% CI) | Positive predictive value (95% CI) | Specificity (95% CI) | Negative predictive value (95% CI) | Accuracy (95% CI) | |
|---|---|---|---|---|---|
All | 84% (80–88) | 80 (75–84) | 97 (94–99) | 97 (96–99) | 95 (92–98) |
Age < 50 | 90% (86–95) | 86 (80–91) | 94 (90–97) | 96 (93–99) | 93 (89–97) |
Age > 50 | 74% (66–83) | 70 (61–79) | 97 (94–100) | 98 (95–101) | 96 (92–100) |
Female | 83% (78–88) | 80 (75–86) | 97 (95–99) | 98 (95–100) | 95 (92–98) |
Male | 87% (79–96) | 77 (67–88) | 93 (87–99) | 96 (92–101) | 92 (85–99) |
Lower comorbidity | 86% (80–91) | 84 (78–90) | 97 (94–100) | 97 (94–100) | 95 (91–98) |
Higher comorbidity | 81% (74–89) | 73 (65–82) | 96 (93–100) | 98 (95–100) | 95 (91–99) |
Rural | 86% (80–91) | 86 (79–94) | 98 (94–101) | 98 (94–101) | 96 (92–100) |
Urban | 83% (78–88) | 77 (71–83) | 96 (93–99) | 97 (95–100) | 94 (91–98) |
Lower income | 86% (79–94) | 75 (66–84) | 96 (92–100) | 98 (95–101) | 95 (90–100) |
Higher income | 83% (78–89) | 82 (76–87) | 97 (94–99) | 97 (95–100) | 95 (92–98) |
Year < 2006 | 90% (84–96) | 73 (64–81) | 94 (90–99) | 98 (96–101) | 94 (89–99) |
Year > 2006 | 81% (75–87) | 84 (78–90) | 98 (95–100) | 97 (94–100) | 95 (92–99) |